United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 5 minute read General business news MHA PLC moves towards London AIM listing with £125m fundraise amid FRC investigation MHA’s AIM listing and £125 million fundraise could shape the UK professional services market. Find out how the FRC investigation may impact investor sentiment. byPallavi MadhirajuMarch 22, 2025